Breakthrough injection aims to free patients from daily pill burden
Disease control
Completed
This trial tested whether a daily injection called TransCon PTH could help adults with hypoparathyroidism better control their blood calcium levels. For the first 26 weeks, some participants received the real injection while others received a placebo, and neither they nor their d…
Phase: PHASE3 • Sponsor: Ascendis Pharma Bone Diseases A/S • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC